Caricamento...
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6), are associated with increased risk of cardiovascular events...
Salvato in:
| Pubblicato in: | Front Cardiovasc Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6403155/ https://ncbi.nlm.nih.gov/pubmed/30873416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00016 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|